Русский
The role of a group of drug users in the development of the HIV infection epidemic on the example of the Moscow Region
DOI: https://dx.doi.org/10.18565/epidem.2023.13.3.49-55
Drobyshevskaya E.V., Zhukova E.V., Bobkova M.R.
1) Center for the Prevention and Control of AIDS and Infectious Diseases, Moscow, Russia; 2) I.I. .Mechnikov Research Institute of Vaccines and Serums, Moscow, Russia
Materials and methods. The data of personalized records of patients with HIV infection in the Moscow region, presented in the primary medical records of the AIDS Center, in the AIDS Info System computer database of the AIDS Center and medical information systems, as well as data from forms of federal statistical monitoring, were analyzed.
Results. A decrease in the significance of HIV transmission through intravenous drug use has been identified, but the true prevalence of the disease among drug users remains an open question. The arguments for the low level of HIV case detection were the decrease in the proportion of drug users among those tested for HIV infection, as well as the high proportion of people who became infected through intravenous drug use among cases of posthumously confirmed HIV diagnosis by the forensic medical examination service. An annual decrease in the proportion of drug users with severe immunodeficiency among those enrolled in care has been registered.
Conclusion. There is evidence to support a reduction in the importance of HIV transmission through intravenous drug use, but the issue of a «hidden» HIV infection epidemic among drug users requires further study.
Literature
1. Борьба со СПИДом в мире замедлилась: миллионам людей грозит смертельная опасность. https://news.un.org/ru/ story/2022/07/1428442 (The fight against AIDS in the world has slowed down: millions of people are in mortal danger). (In Russ,). https://news.un.org/ru/story/ 2022/07/1428442 2. ЮНЭЙДС. Информационный бюллетень 2022. Глобальная статистика по ВИЧ и СПИДу. https://www.unaids.org/en/resources/fact-sheet (UNAIDS. Fact sheet 2022. Global HIV & AIDS statistics). (In Russ.). https://www.unaids.org/en/resources/fact-sheet 3. Выдержки из доклада о наркоситуации в Московской области в 2021 году. Антинаркотическая комиссия в Московской области. https://ank.mosreg.ru/dokumenty/otkrytye-dannye/11-05-2022-13-17-52-vyderzhki-iz-doklada-o-narkosituatsii-v-moskovskoy (Excerpts from the report on the drug situation in the Moscow region in 2021. Anti-Drug Commission in the Moscow Region). (In Russ.). https://ank.mosreg.ru/dokumenty/otkrytye-dannye/11-05-2022-13-17-52-vyderzhki-iz-doklada-o-narkosituatsii-v-moskovskoy 4. Киржанова В.В., Григорова Н.И., Бобков Е.Н., Киржанов В.Н., Сидорюк О.В. Состояние и деятельность наркологической службы Российской Федерации в 2021 году. Аналитический обзор. М.: ФГБУ «НМИЦ ПН им. В.П. Сербского» Минздрава России, 2022. 202 с. Kirzhanova V.V., Grigorova N.I., Bobkov E.N., Kirzhanov V.N., Sidoryuk O.V. (The state and activities of the narcological service of the Russian Federation in 2021. Analytical review). Moscow, 2022. 202 p. (In Russ.). 5. Доклад о наркоситуации в Российской Федерации в 2020 году. Государственный антинаркотический комитет. М., 2021. (Report on the drug situation in the Russian Federation in 2020). State Anti-Drug Committee. Moscow, 2021. (In Russ.). 6. Ладная Н.Н., Покровский В.В., Соколова Е.В., Чекрыжова Д.Г. Распространенность ВИЧ-инфекции среди потребителей инъекционных наркотиков на территории Сибирского федерального округа. Эпидемиол. инфекц. болезни. Актуал. вопр. 2021; 11(4): 7–13. DOI: 10.18565/epidem.2021.11.4.7-13 Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G. The prevalence of HIV infection among injecting drug users in the Siberian Federal District. Epidemiology and infectious diseases. Current items 2021; 12(4): 7–13. (In Russ.). DOI: 10.18565 epidem.2021.11.4.7-13
About the Autors
Elena V. Drobyshevskaya, Deputy Chief Physician for the Medical Affairs, Center for the Prevention and Control of AIDS and Infectious Diseases, Moscow Region, Moscow, Russia; elena_dr@bk.ru; https://orcid.org/0000-0002-0654-8646
Eugenia V. Zhukova, Head, Department of Epidemiology and Prevention, Center for the Prevention and Control of AIDS and Infectious Diseases, Moscow Region, Moscow, Russia; zhukovazh@mail.ru; https://orcid.org/0000-0002-3390-1302
Marina R. Bobkova, ВD, Chief Specialist, I.I.Mechnikov Research Institute of Vaccines and Serums, Moscow, Russia; mrbobkova@mail.ru; https://orcid.org/0000-0001-5481-8957; SPIN: 3912-8165
Similar Articles
